Agilent Technologies and Incyte have signed an agreement to create companion diagnostics tests, bringing the two Delaware companies together in the future of cancer treatments.
© 2024 Delaware Business Times
Important notice for access to your Delaware Business Times “Insider” content
Flash Sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.